José Antonio García Erce: Situation of Immunoglobulins in Spain
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared a post on LinkedIn about a recent article by Pierre Tiberghien et al, published in Vox Sanguinis:
”Situation of immunoglobulins in Spain.
Is there a lack of transparency or interest on the part of the authorites? (Part 2)
In 2023, in December, Europe included Inmunoglobulinas Anti -D (Ig ) in the list of fármacos críticos (Union list of critical medicines – version 2.1 (revision January 2026) [J06BB01 human anti – D immunoglobulin] along with the rest of the hemoderivados plasmáticos.
On October 2024, a brief survey was launched from the European Blood Alliance to all member countries to ‘learn about the current situation of anti-D plasma collection and explore the possibilities of implementing programs of this type in Europe’.
The results have been included in a recent paper published by the European Committee on Blood Transfusion (CD-P-TS) of the European Directorate for the Quality of Medicines and HealthCare (EDQM), Council of Europe entitled ‘Can we have European anti – D plasma collection programes?‘
A total of 23 responses were received from 19 countries: ‘None of the countries surveyed had an active national anti-D plasma collection programme.’ Unfortunately there was no response from Spain. ¿?
On July 4, 2025, the European Medicine Agency (EMA) published an important document dated June 23: ‘Strengthening supply chain of anti-D immunoglobulins.’
‘Recommendations of the Executive Steering Group on Drug Shortages and Safety to Address Anti-D Immunoglobulin Supply Chain Vulnerabilities.’
Where they include three blocks of recommendations:
- for member states
- for the European Commission
- for the plasma industry and ‘relevant’ research organizations.
I miss that the Scientific Societies involved are included, such as the European Hematology Association (EHA), the FIGO (International Federation of Gynecology and Obstetrics) and the International Society of Blood Transfusion (ISBT).
Once again I wonder, why does the Ministry of Health and Consumer Affairs
General Directorate of Public Health. Subdirectorate General of Health Promotion and Epidemiology, as a member of the European Blood Alliance did not answer the survey?
Is it not of interest or is there no concern?
When the front page of the European Blood Alliance website since March 25 includes this headline: ‘Securing the future of anti – D immunoprophylaxis in Europe’ ”
Title: Achieving sustainable anti-D immunoprophylaxis in Europe
Authors: Pierre Tiberghien, Dragoslav Domanović, Richard Forde, Peter O’Leary, Joanne Verweij, C. Ellen van der Schoot
Reaf the Full Article on Vox Sanguinis
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy